Brief: Acurx Pharmaceuticals Announces Presentation Of Results From Leiden University Medical Center Public-Private Partnership For Its DNA pol IIIC Inhibitors
09/06/2025 13:08
June 9 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS ANNOUNCES PRESENTATION OF RESULTS FROM LEIDEN UNIVERSITY MEDICAL CENTER PUBLIC-PRIVATE PARTNERSHIP FOR ITS DNA POL IIIC INHIBITORS AT THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY SCIENTIFIC CONFERENCE Source text: ID:nPn4xwlCKa Further company coverage: ACXP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program